BASF Corp. is buying Verenium Corp. (Nasdaq: VRNM) for $62 million.

Verenium, headquartered in San Diego, Calif., extracts microbial DNA from samples to identify enzymes used in the company’s animal health, nutrition, grain processing and oilfield services products.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.